← All indications
Colonic Diseases
Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
Subtype terms (8)
More specific conditions that are subtypes of Colonic Diseases in the MeSH hierarchy.
- Chilaiditi Syndrome
- Colitis
37 drugs (23 approved, 14 experimental)
- Colonic Diseases, Functional
10 drugs (5 approved, 5 experimental)
- Colorectal Neoplasms
1516 drugs (399 approved, 1117 experimental)
- Diverticulosis, Colonic
7 drugs (6 approved, 1 experimental)
- Low Anterior Resection Syndrome
2 drugs experimental
- Megacolon
1 drug approved
- Sigmoid Diseases
Drugs by status
Phase 4 trials (12)
Phase 3 trials (9)
Phase 2 trials (19)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (11)
- Symyoo
- CTC Bio, Inc.
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Maastricht University
- Tanta University
- University of Toronto
- Badalona Hospital Germans Trias i Pujol
- Catholic University of Korea
- University of North Carolina at Chapel Hill
- Pharmbio Korea
Organization Involved with Phase 2 Indications (34)
- Bausch Health Companies
- Merck
- Catalysis SL
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- Kyowa Hakko Kirin
- gicare Pharma Inc.
- Chang Gung University
- Changhua Christian Hospital
- Chimei Medical Center
- National Cheng Kung University
- The Canadian College of Naturopathic Medicine
- University of South Florida
- Mayo Clinic
- Chinese University of Hong Kong
- Taichung Veterans General Hospital
- University of British Columbia
- Zhejiang University
- Algorithme Pharma Inc
- The Center of GI Disorders, Hollwood, FL, USA
- Precision Research Institute
- Toronto Digestive Disease Associates, Toronto, ON, Canada
- Mid-Atlantic Medical Research Centers, Hollyword, MD
- Gastroenterology Associates of Orangeburg, SC
- PharmaTrials
- Anaheim Clinical Trials
- Avail Clinical Research
- Janssen Pharmaceutica NV
- Wakunaga Pharmaceutical Co., Ltd.
- JSS Medical Research Inc.
- Dicentra Inc.
- +4 more
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (6)